DV Trading’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$102M Hold
1,439,393
– – 3.29% 10
2026
Q2
$102M Hold
1,439,393
– – 3.35% 8
2026
Q1
$97.4M Hold
1,439,393
– – 2.31% 11
2025
Q4
$59.8M Buy
+1,439,393
New +$59.6M 1.68% 15

Other funds holding CGON

DV Trading's CGON Position: Q3 2026 in Review

DV Trading held its CG Oncology (CGON) position steady in Q3 2026 at 1,439,393 shares worth $102M. The position accounts for 3.29% of the portfolio, ranked #10.

DV Trading first reported a position in CGON in Q4 2025 and has held it in 4 quarters since. The position peaked at $102M in Q2 2026. 233 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • DV Trading held 1,439,393 shares of CG Oncology worth $102M as of Q3 2026.
  • DV Trading left its CG Oncology share count unchanged in Q3 2026.
  • CG Oncology made up 3.29% of DV Trading's portfolio in Q3 2026, its #10 holding.
  • DV Trading first reported a position in CG Oncology in Q4 2025 and has held it in 4 quarters since.
  • DV Trading's CG Oncology position peaked at $102M in Q2 2026.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on DV Trading's 13F filing for Q3 2026, filed 16 Nov 2026.